Zhe Wang

机构：Zhongda Hospital Southeast University, Clover Biopharmaceuticals (China), Shandong Provincial Hospital, Qilu Hospital of Shandong University · ORCID：0000-0001-5407-4230

发表论文 296 篇 · 总被引 4776 次 · h-index 37

代表论文

• Kaempferol as a multifaceted immunomodulator: implications for inflammation, autoimmunity, and cancer (2025 · Frontiers in Immunology · 被引 22)
• Lactate metabolic checkpoint in immuno-oncology: mechanisms and therapeutic implications (2025 · Cancer Letters · 被引 15)
• Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis (2025 · Frontiers in Immunology · 被引 6)
• Targeting phosphatidylserine in tumor cell membranes with a zinc-containing molecule to efficiently combat tumor metastasis (2025 · Journal of Nanobiotechnology · 被引 4)
• Full Active Nanoplatform Restores ROS Homeostasis for Synergistic Therapy of Fatty Liver Disease via Dual Endogenous–Exogenous Pathways (2025 · ACS Applied Materials & Interfaces · 被引 3)
• Exploring secondary extramedullary myeloma disease: a five-predictor scoring system with spotlight on double-hit cytogenetics (2025 · BMC Medicine · 被引 3)